VisMederi Research Partner of the PANVIR.NET Project

Recent demographic and climatic changes have led to a greater spread of arboviruses such as Dengue, Chikungunya, Zika, West Nile and new influenza virus subtypes, as well as to an increased risk of new infections or reactivation of persistent ones, including herpes infections...
Leggi/Read →

VisMederi Research: good results for “INSIDE” research project.

The project, in which VisMederi Research is a partner, is aimed at developing diagnostic and theranostic targeting based on nanosystems and/or engineered lymphocytes for the early detection and treatment of melanoma, and multiple sclerosis. With its participation in the INSIDE...
Leggi/Read →

VisMederi’s expertise in meningitidis is growing also with opinions from Dr. Rino Rappuoli.

“An unwanted guest: Neisseria meningitides – carriage, risk for invasive disease and the impact of vaccination with insights from Italy incidence”. Gianchecchi E1, Piccini G1,2, Torelli A1,2, Rappuoli R3, Montomoli E1,4. Invasive Meningococcal Disease (IMD)...
Leggi/Read →

New research on Toscana Virus in collaboration between University of Siena and VisMederi srl

“Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy”.  Marchi S, Trombetta CM, Kistner O, Montomoli E. Sandfly fever viruses are transmitted by the bite of phlebotomine sandflies;...
Leggi/Read →

VisMederi is research partner in the ADITEC Project – 2016 Annual Meeting in Brussels and event at the European Parliament.

VisMederi will be present also this year at the Annual Meeting of ADITEC project to be held in Brussels on November 7 to 9 in 2016. ADITEC (Advanced Immunization Technologies) is a five-year project that began in 2011 thanks to the collaboration of scientists from 13 countries...
Leggi/Read →

Prof. Montomoli at EDUFLUVAC Annual Meeting 2016 – Towards the Development of a Vaccine against “Universal” Flu

Emanuele Montomoli, CSO of VisMederi and Professor of Public Health at the University of Siena, will take part as a member of the Scientific Committee at EDUFLUVAC Annual Meeting 2016 to be held in Zurich on 20 and 21 October 2016. EDUFLUVAC is a four-year cooperation project...
Leggi/Read →

VisMederi in Barcelona for the 2016 World Vaccine Congress

As usual, VisMederi will be present this year too at the World Vaccine Congress, the leading event in Europe in the field of vaccines, now at its 17th edition, to be held in Barcelona October 10 to 12, 2016. The Congress will discuss the ongoing works in the vaccine field, with...
Leggi/Read →

VisMederi CSO Emanuele Montomoli in Ethiopia at the Ministerial Conference on Immunization in Africa

Prof. Emanuele Montomoli is joining the closure meeting of the Meningitis Vaccine Project (MVP) in Addis Abeb, Ethiopia, where is ongoing the Ministerial Conference on Immunization in Africa. MVP is a partnership between PATH and the World Health Organization promote to eliminate...
Leggi/Read →

A 400,000-euro investment for three innovative R&D projects funded by the Tuscany Region

The Tuscany Region financed three innovative R&D projects involving VisMederi. The winning ideas, Magic- Theravax, Inside and Innoviral, are among the 138 projects presented by small, medium and large enterprises that the Region funded for a total of over 40 million euros, on...
Leggi/Read →

Le Scienze

01.07.201 Al servizio della ricerca Sul numero di luglio del mensile Le Scienze, edizione italiana di Scientific American, la giornalista Letizia Gabaglio racconta la nostra storia al servizio della ricerca. Due pagine di approfondimento nello spazio dedicato alle imprese made in...
Leggi/Read →